Capital World Investors 13D/13G Filings for NewAmsterdam Pharma Company N.V. (NAMS)

Capital World Investors 13D and 13G filings for NewAmsterdam Pharma Company N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-13
7:06 pm
Purchase
2025-09-3013GNewAmsterdam Pharma Company N.V.
NAMS
Capital World Investors9,822,711
8.700%
1,434,986increase
(+17.11%)
Filing
2025-08-13
12:56 pm
Purchase
2025-06-3013GNewAmsterdam Pharma Company N.V.
NAMS
Capital World Investors8,387,725
7.500%
1,589,127increase
(+23.37%)
Filing
2025-05-13
11:44 am
Purchase
2025-03-3113GNewAmsterdam Pharma Company N.V.
NAMS
Capital World Investors6,798,598
6.200%
6,798,598increase
(New Position)
Filing